In this study, we examined the eŠectiveness of chitosan capsules for the colon-speciˆc delivery of prednisolone in rats. We also evaluated the eŠectiveness and side eŠects of prednisolone using chitosan capsules compared with the conventional dosage form (gelatin capsules). We found a signiˆcant increase in the concentration of prednisolone in the large intestinal mucosa when prednisolone was administered orally using chitosan capsules, as compared with the case using gelatin capsules. On the other hand, the plasma concentrations of prednisolone after oral administration using chitosan capsules were much lower than those in the case of gelatin capsules. We also assessed the eŠectiveness of prednisolone for the healing of trinitrobenzene sulfonic acid-induced colitis by measuring myeloperoxidase (MPO) activity and colon wet weight/body weight (C/B) ratio. MPO activities and C/B ratios were signiˆcantly reduced when prednisolone was administered orally using chitosan capsules, in comparison with the case of gelatin capsules. Moreover, the weight of the thymus, which is an index of the side eŠects of prednisolone, markedly decreased after oral administration of prednisolone using gelatin capsules, whereas its weight did not change as much when prednisolone was administered orally using chitosan capsules. Theseˆndings indicate that chitosan capsules might be useful for the colon-speciˆc delivery of prednisolone and its enhanced eŠectiveness for the healing of colitis in rats. Moreover, chitosan capsules might be also eŠective in reducing the side eŠects of prednisolone due to its decreased intestinal transfer to the systemic circulation.

